65 related articles for article (PubMed ID: 7323098)
1. Studies on a 5 alpha-reductase inhibitor and their therapeutic implications.
Petrow V; Lack L
Prog Clin Biol Res; 1981; 75B():283-97. PubMed ID: 7323098
[No Abstract] [Full Text] [Related]
2. Prostatic cancer. I. 6-Methylene-4-pregnen-3-ones as irreversible inhibitors of rat prostatic delta 4-3 ketosteroid 5 alpha-reductase.
Petrow V; Wang Y; Lack L; Sandberg A
Steroids; 1981 Aug; 38(2):121-40. PubMed ID: 7303026
[TBL] [Abstract][Full Text] [Related]
3. Steroidal inhibitors of prostatic 5alpha-reductase: structure-activity relationships.
Dupuy GM; Roberts KD; Bleau G; Chapdelaine A
J Steroid Biochem; 1978 Nov; 9(11):1043-7. PubMed ID: 745402
[No Abstract] [Full Text] [Related]
4. Approaches to prostatic 5 alpha-reductase inhibitors.
Batzold FH
Prog Clin Biol Res; 1981; 75B():269-82. PubMed ID: 6172801
[No Abstract] [Full Text] [Related]
5. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Kadohama N; Karr JP; Murphy GP; Sandberg AA
Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158
[TBL] [Abstract][Full Text] [Related]
6. Prostatic cancer--II. Inhibitors of rat prostatic 4-ene-3-ketosteroid 5 alpha-reductase derived from 6-methylene-4-androsten-3-ones.
Petrow V; Wang YS; Lack L; Sandberg A; Kadohama N; Kendle K
J Steroid Biochem; 1983 Oct; 19(4):1491-502. PubMed ID: 6645489
[TBL] [Abstract][Full Text] [Related]
7. Preparation of 20-(hydroxymethyl)-4-methyl-4-aza-2-oxa-5 alpha-pregnan-3-one as an inhibitor of testosterone 5 alpha-reductase.
Weintraub PM; Blohm TR; Laughlin M
J Med Chem; 1985 Jun; 28(6):831-3. PubMed ID: 4009607
[TBL] [Abstract][Full Text] [Related]
8. Properties of testosterone 5 -reductase of purified nuclear fraction from ventral prostate of rats.
Shimazaki J; Horaguchi T; Oki Y; Shida K
Endocrinol Jpn; 1971 Apr; 18(2):179-87. PubMed ID: 4105278
[No Abstract] [Full Text] [Related]
9. Attenuation by a 5 alpha-reductase inhibitor of the activational effect of testosterone propionate on penile erections in castrated male rats.
Bradshaw WG; Baum MJ; Awh CC
Endocrinology; 1981 Oct; 109(4):1047-51. PubMed ID: 7285860
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of some steroidal 6-methylene derivatives on 5 alpha-reductase activity in human and rat prostate.
Kadohama N; Petrow V; Lack L; Sandberg AA
J Steroid Biochem; 1983 May; 18(5):551-8. PubMed ID: 6855230
[TBL] [Abstract][Full Text] [Related]
11. Partial characterization of the nuclear reduced nicotinamide adenine dinucleotide phosphate: delta 4-3-ketosteroid 5 alpha-oxidoreductase of rat prostate.
Frederiksen DW; Wilson JD
J Biol Chem; 1971 Apr; 246(8):2584-93. PubMed ID: 4396507
[No Abstract] [Full Text] [Related]
12. Potential test systems for drugs against prostatic cancer.
Sandberg AA; Kirdani RY; Yamanaka H; Varkarakis MJ; Murphy GP
Cancer Chemother Rep; 1975; 59(1):175-84. PubMed ID: 1131803
[TBL] [Abstract][Full Text] [Related]
13. Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase.
Kadohama N; Wakisaka M; Kim U; Karr JP; Murphy GP; Sandberg AA
J Natl Cancer Inst; 1985 Feb; 74(2):475-86. PubMed ID: 3856054
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity labelling of nuclear steroid 5 alpha-reductase of rat ventral prostate.
Enderle-Schmitt U; Seitz J; Aumüller G
J Steroid Biochem; 1989 Sep; 33(3):379-87. PubMed ID: 2779229
[TBL] [Abstract][Full Text] [Related]
15. Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.
Brooks JR; Baptista EM; Berman C; Ham EA; Hichens M; Johnston DB; Primka RL; Rasmusson GH; Reynolds GF; Schmitt SM; Arth GE
Endocrinology; 1981 Sep; 109(3):830-6. PubMed ID: 7262023
[No Abstract] [Full Text] [Related]
16. Sexual difference in properties of 5 alpha-reductase in microsome of rat submandibular glands.
Koshika S; Hosaka M; Tarui M; Furuyama M; Nakayama Y
Biochem Int; 1987 Oct; 15(4):761-8. PubMed ID: 3435539
[TBL] [Abstract][Full Text] [Related]
17. Solubilization of testosterone 5 alpha-reductase from nuclear fraction of rat ventral prostate.
Shimazaki J; Oki Y; Kurihara H; Furuya N; Shida K
Endocrinol Jpn; 1973 Oct; 20(5):489-95. PubMed ID: 4151873
[No Abstract] [Full Text] [Related]
18. Partial characterization of stromal and epithelial forms of 5 alpha-reductase in human prostate.
Bruchovsky N; McLoughlin MG; Rennie PS; To MP
Prog Clin Biol Res; 1981; 75A():161-75. PubMed ID: 6175974
[No Abstract] [Full Text] [Related]
19. Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes.
Liang T; Heiss CE; Ostrove S; Rasmusson GH; Cheung A
Endocrinology; 1983 Apr; 112(4):1460-8. PubMed ID: 6832056
[TBL] [Abstract][Full Text] [Related]
20. The development of a male pseudohermaphroditic rat using an inhibitor of the enzyme 5 alpha-reductase.
Imperato-McGinley J; Binienda Z; Arthur A; Mininberg DT; Vaughan ED; Quimby FW
Endocrinology; 1985 Feb; 116(2):807-12. PubMed ID: 3967629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
